Lifestyle Delivery Systems Announces Results of its Annual General Meeting

Vancouver, British Columbia--(Newsfile Corp. - January 29, 2018) - Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF) (FSE: LD6) (WKN: A14XHT) ("LDS" or the "Company") is pleased to announce the results of its Annual General Meeting (the "AGM") held on January 25, 2018.

At the AGM, shareholders of the Company:

• Set the number of directors of the Company for the ensuing year at six (6) persons;
• Elected Brad Eckenweiler, James Pakulis, Dr. John Sanderson, Yanika Silina, David Velisek and Arni Johannson as the Company's directors for the ensuing year;
• Re-appointed Dale Matheson Carr-Hilton Labonte LLP as the auditors of the Company for the ensuing year, and authorized the directors to fix the remuneration to be paid to the auditors;
• Passed a special resolution amending the articles of the Company to incorporate advance notice provisions as set forth in the Company's Management Information Circular dated December 22, 2017.

The Company expects to post the video recording of the highlights of the AGM on its website during the week of January 29^th, 2018.

About Lifestyle Delivery Systems Inc.

The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking, but also a new way to accurately meter the dosage and assure the purity of the product. In addition, with the entering into its management services agreements with NHMC, Inc. and CSPA Group, Inc., the Company has begun its direct involvement in the growing of medicinal ingredients for, and the manufacturing of, its products. From seed to sale, the Company's products and ingredients will be tested for quality and composition throughout the formulation and production processes, resulting in a delivery system that is safe, consistent and effective.

On behalf of the board of directors of Lifestyle Delivery Systems Inc.

Brad Eckenweiler, CEO & Director

FOR MORE INFORMATION, PLEASE CONTACT:

[email protected]
1-866-347-5058

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.